Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ October 2, 2022 ] Biomechanics consultant – Semper Scientific – Mission Viejo, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] Product Quality Lead – CAPRICOR THERAPEUTICS, INC – Los Angeles, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] Sr. Biomanufacturing Manager, Upstream & Downstream (Cell & Gene Therapy) – Avid Bioservices – Tustin, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] Scientist, Analytical Development – Atara Biotherapeutics, Inc. – Thousand Oaks, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] GMP Project Engineer/Sr. Engineer, Capital Projects – Avid Bioservices – Tustin, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsArrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)

September 24, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead reports inducement grants

Click to view original post

Previous

Capricor Therapeutics to Present Results from the HOPE-2 Trial with CAP-1002 in Duchenne Muscular Dystrophy at the International World Muscle Society Virtual Congress 2020

Next

Silverback dishes out two promotions in C-suite; Legend CEO post changes hands again

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered